MPM BioVentures 2014, L.P. Plans to Sell Shares in Werewolf Therapeutics, Inc.

MPM BioVentures 2014, L.P. has filed a Form 144 with the SEC indicating its intention to sell 130,125 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The planned sale is expected to occur around October 27, 2025, with an aggregate market value of approximately $230,321.25. The filing also confirms that there have been no sales of securities by MPM BioVentures 2014, L.P. in the past three months. The shares are listed on NASDAQ, and Merrill Lynch is the broker involved in the transaction.